Emerging evidence have posited that dysregulated microglia impair clearance and containment of amyloid-β (Aβ) species in the brain, resulting in aberrant buildup of Aβ and onset of Alzheimer's disease (AD). Hematopoietic cell kinase (Hck) is one of the key regulators of phagocytosis among the Src family tyrosine kinases (SFKs) in myeloid cells, and its expression is found to be significantly altered in AD brains. However, the role of Hck signaling in AD pathogenesis is unknown. We employed pharmacological inhibition and genetic ablation of Hck in BV2 microglial cells and J20 mouse model of AD, respectively, to evaluate the impact of Hck deficiency on Aβ-stimulated microglial phagocytosis, Aβ clearance, and resultant AD-like neuropathology.
| INTRODUCTION
Recent studies strongly support that accelerated buildup of amyloidbeta (Aβ) in the brain is primarily mediated by an impairment of Aβ clearance, rather than the overproduction of Aβ in Alzheimer's disease (AD) (Mawuenyega et al., 2010; Querfurth & LaFerla, 2010; TarasoffConway et al., 2015; Wildsmith, Holley, Savage, Skerrett, & Landreth, 2013) . Microglia, the resident immune cells in the brain, are believed to play a key role in removing Aβ species and regulating neuroinflammation (Cunningham, 2013; Eikelenboom et al., 2002; Malm, Jay, & Landreth, 2015) . Our previous studies have shown that inhibiting microglial phagocytosis and activating proinflammatory responses exacerbate AD neuropathology while stimulating microglial phagocytosis clears Aβ and rescues cognition (Dunn et al., 2015; Medeiros et al., 2013) . It is thus evident that functional inactivation of microglia significantly impair its ability to clear Aβ, leading to a pathological buildup of Aβ and the onset of AD (Lim, Rodriguez-Ortiz, & Kitazawa, 2015) . In support of this notion, a recent longitudinal human study reveals an early protective peak and a late proinflammatory peak of microglial activation in the pathogenesis of AD (Fan, Brooks, Okello, & Edison, 2017) . Hence, identifying molecules or signaling pathways that mediate microglial dysregulation in the pathogenesis of AD is a key to retard or halt the progression of the disease (Wes, Sayed, Bard, & Gan, 2016) .
A plethora of evidence have shown that in vitro and in vivo Aβ stimulation of microglia augments tyrosine phosphorylation Dhawan, Floden, & Combs, 2012) , which correlates with elevated levels of microglial phospho-tyrosine and phospho-Src in AD brains (Dhawan, Floden, & Combs, 2012; Wood & Zinsmeister, 1991) . Hematopoietic cell kinase (Hck) is a member of the Src family tyrosine kinases (SFKs) which mediate immunoreceptor-induced phagocytic activation in microglia (Choucair et al., 2006; Linnartz & Neumann, 2013) , while spleen tyrosine kinase (Syk) is a nonreceptor tyrosine kinase acting downstream of SFKs (Lowell, 2011) . Integrative network-based approach analyzing 1,647 postmortem brain tissues of AD patients and nondemented subjects identified eight common causal regulators for all immune networks, and Hck was ranked third after TYROBP (DAP12) and DOCK2, based on combined ranking score of regulatory strength and differential expression in AD brains (Zhang et al., 2013) .
SFKs mediate Aβ-stimulated microglial phagocytosis (Koenigsknecht & Landreth, 2004) , and Hck is the key regulator of phagocytosis in myeloid cells among the SFKs (Guiet et al., 2008; Lowell, Soriano, & Varmus, 1994) . However, there is no direct study on the effect of Hck regulation on Aβ-stimulated microglial phagocytosis to date. We hypothesize that inactivation of Hck and Syk impairs microglial phagocytosis and Aβ clearance, leading to the development of AD neuropathology and cognitive decline. To test our hypothesis, we conducted in vitro inhibition of SFKs/Hck in BV2 microglial cells, genetic ablation of Syk in primary microglia, and in vivo ablation of
Hck in J20 mouse model of AD to evaluate the impact of Hck deficiency on Aβ-stimulated microglial phagocytosis, Aβ clearance, and resultant AD-like neuropathology. This study will be the first that evaluates the deficiency of Hck in AD-like pathology, thereby providing knowledge for therapeutic interventions for treating AD.
| MATERIALS AND METHODS

| 7PA2, CHO, and primary microglial cell culture
7PA2 cells are transfected Chinese hamster ovary (CHO) cells that express V717F AD mutation in amyloid-β precursor protein 751 (AβPP 751 ) (Walsh et al., 2002) . Upon cell confluent, 7PA2 cells secrete Aβ monomers and oligomers naturally in the conditioned medium (CM). Both 7PA2 and control CHO cells were kindly contributed by Dr Edward Koo (University of California, San Diego, CA), and were grown in Dulbecco's Modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 50 units penicillin, and 50 μg streptomycin (Thermo Fisher Scientific, Inc.). When cells were near confluent, they were washed once with serum-free medium (SFM) and replaced with fresh stock of the same medium. Cells were then incubated for~16 hr, and the CM was collected and centrifuged at 1000g for 10 min at 4 C to remove cell debris. CM were then stored at −80 C until Aβ 40 and Aβ 42 quantification using enzymelinked immunosorbent assay (ELISA) as described in Section 2.8.
7PA2-CM with substantiate expression of Aβ 40 (352-570 pM) and
Aβ 42 (320-480 pM), but negligible levels of the same proteins in CHO-CM were applied to BV2 cells and primary microglia for phagocytosis assay and to BV2 cells for biochemical analysis.
Primary microglia were isolated from Syk/Cre double homozygous mice on postnatal day 0-3. Syk/Cre mice were generated by crossing Syk-floxed (#017309 from the Jackson Laboratory) and Rosa
Cre-ERT2 mice (#008463 from the Jackson Laboratory) to allow in vitro 4-hydroxytamoxifen (4-OHT, Sigma-Aldrich Corporation)-inducible deletion of Syk (Ozaki et al., 2012) . Extraction of primary microglia was done as described (Tanaka, Murakami, Bando, & Yoshida, 2015) with some modifications. Briefly, mouse brains were collected in culture medium as described above and microdissected to remove olfactory bulb, cerebellum, and meninges. Thereafter, the brain tissues were triturated with micropipette tips, digested in 0.05%
Trypsin-EDTA for 15 min at 37 C and filtered through 70 μm nylon cell strainer (BD Falcon). Cell suspension from six to nine pups were combined and cultured in one T-75 flask, and after an overnight incubation, cells were replenished with fresh medium and allowed to grow for 7-10 days without changing medium. Microglial cells growing on top of the astrocytes monolayers were isolated by shaking the culture flask.
| In vitro phagocytosis assay and biochemical analysis
BV2 cells are immortalized murine microglial/macrophage cells that elicit robust phagocytic activity upon stimulation (Kopec & Carroll, 1998) . The BV2 cells used in this assay were kindly provided by Dr Gary Landreth (Case Western Reserve University). Cells were cultured in DMEM supplemented with 5% FBS, 50 units penicillin, and 50 μg streptomycin. in vitro phagocytosis assay was conducted as established by several groups (Koenigsknecht & Landreth, 2004; Koenigsknecht-Talboo & Landreth, 2005; Pan et al., 2011; Song, Zhou, & Chen, 2012) System (Thermo Fisher Scientific Inc.) using a 20× objective. Number of microspheres phagocytosed by each cell were counted manually using the Cell Counter plugins on ImageJ software (National Institute of Health) and expressed as phagocytic efficiency (%) and % phagocytic cells as described (Koenigsknecht & Landreth, 2004) . To determine phagocytic efficiency (%), points were assigned according to the number of microspheres per cell wherein one point was given for a cell phagocytosing one microsphere, two points for two microspheres, and so on, up to a maximum of six points for more than five microspheres phagocytosing per cell. Number of cells containing
x microspheres in the image was next multiplied by the point value.
Each of these values were then added together and divided by the total number of cells counted. To express in terms of % phagocytic cells, number of cells phagocytosing one or more microspheres were taken relative to the total number of cells counted in the image. Averaged value from the three images per well thus represented one data value and was compared with that of other treatments in replicates.
To assess the signaling pathways mediating ligand-stimulated BV2 cells phagocytosis, cells were plated at 5 × 10 5 cells/well on 6-well plate to achieve 80% confluency by the following day. Cells were rinsed once with SFM before incubated in fresh SFM for another 3 hr. Cells were then treated with either SFM or 10 μM PP2 for 30 min. Thereafter, cells were replenished with either SFM (control), mOZ (1 mg/ml), 7PA2-or CHO-CM, and incubated for 60 min. For wells that were previously treated with PP2, they were replenished with mOZ or 7PA2-CM spiked with PP2. At the end of the incubation, Primary microglial phagocytosis assay was conducted as described for BV2 cells with some modifications. Primary microglia were seeded at 60 × 10 3 cells/well on CC2™ Chamber Slide System (Thermo Fisher Scientific Inc.) and incubated for 30 min in culture medium before washing twice with PBS to remove oligodendrocytes precursor cells. Primary microglia were then cultured overnight in mixed glia-CM before treating some of the cells with 0.6 μM 4-OHT for 4 days, followed by culture medium for 1 day, to knockdown Syk.
On day 6, cells were prepared for in vitro phagocytosis assay as described above, using mOZ (1 mg/ml), 7PA2-, or CHO-CM as stimuli.
| Animals
Hck-knocked out (Hck-KO) mice were generously provided by Dr Clifford Lowell (University of California, San Francisco, CA). Hemizygous PDGF-hAPP Sw,Ind J20 mice and wild-type (WT) mice were purchased from Jackson Laboratory. Hck-deficient J20 (J20/Hck-KO) mice was generated by crossing J20 mice with Hck-KO mice. All mice were of C57BL/6 background and both genders were used in this study. Mice were analyzed at 5-8 months old when they are at an early stage of pathological development. All animal studies performed were approved by the University of California Institutional Animal Care and Use Committee and were in accordance with Federal guidelines.
| Tissue collection
Littermates of J20 and WT mice, as well as Hck-KO and J20/Hck-KO mice were euthanized at 6-8 months old after behavioral studies at 5-6 months of age. Mice were perfused with ice-cold PBS and the brains were collected in one of the three ways as followed: (a) for immunostaining, the hemibrain was fixed with 4% PFA; (b) for dendritic spine analysis, the hemibrain was immersed in Golgi solution;
(c) for biochemical analyses, the hemibrain was microdissected into hippocampus and cortex, and frozen at −80 C until further processing.
| Immunohistochemical analysis
Hemibrains designated for immunostaining were cryopreserved in −80 C after fixing in 4% PFA and cryoprotected in 30% sucrose for 2-3 days each. Thereafter, hemibrains were sectioned coronally at 20 μm using a freezing microtome (SM2010R; Leica Biosystems) and sections were stored in PBS with 0.05% sodium azide at 4 C. Sections from different mice at bregma position −2.54 mm (according to the mouse brain atlas of Franklin and Paxinos, Third Edition, 2007) were then mounted on microscopic slides and processed under the same conditions. Negative control slides were prepared by omitting primary antibodies to check for nonspecific labeling.
To assess for Aβ plaque burden, two additional sections (AE10 sections from bregma −2.54 mm) per mouse were pretreated with 90% formic acid for 5 min as modified from previously reported protocols Medeiros et al., 2011) To label Thioflavin-S plaques, sections were stained for 10 min in 0.5% Thioflavin-S (Sigma-Aldrich Corporation) in 50% ethanol (in the dark) without formic acid treatment. Thioflavin-S plaques of ≥30 μm were captured with confocal microscope using a 40× objective with 2× zoom in 1 μm z-separation step. To assess for microglial activities around the plaques, Iba-1 (Wako Laboratory Chemicals), and CD45
and CD11b (AbD Serotec) primary antibodies were used, and were quantified at within 20 μm from the edge of the plaque of diameter ≥30 μm, including the area of the plaque itself (Ulrich et al., 2014) .
CD68 (AbD Serotec) primary antibody was applied to assess the activation of phagolysosomes in microglial cells after Aβ phagocytosis.
pSyk (Tyr525/526) and iNOS antibodies were also used to assess activation of Syk and proinflammatory state of microglia clustering around plaques, respectively. Area covered by respective proteins was measured using ImageJ, while volumetric image measurements, and microglial number and morphology assessment were made using Imaris software (Bitplane Inc.) as previously described (Marsh et al., 2016) .
Plaque sphericity was quantified using the Imaris software to assess the diffusivity of plaques. To determine Aβ internalization ratio, volume of Aβ found within CD68 + phagolysosomes in Iba1 + microglia was normalized to microglial number on the plaque and Aβ plaque volume within the field (Marsh et al., 2016) .
To label synaptic proteins, synaptophysin (Abcam) and PSD95
(NeuroMab) antibodies were applied, and protein intensities in the DG, CA1, and CA3 regions of the hippocampus were quantified. Using a 20× objective on the EVOS FL Cell Imaging System as previously described (Zumkehr et al., 2015) , three different areas in the DG, and two of each in the CA1 and CA3 regions were imaged. In each image, five 50 × 50 pixel area were selected from the four corners and the middle of the image that best represent the protein intensity of the region and were quantified using ImageJ. An average of all areas from each region was calculated and represented the synaptic protein intensities in the DG, CA1, and CA3 regions of the hippocampus. Data are expressed as % synaptic protein intensities per genotype relative to that of Hck-KO mice as the tissues were sectioned in two batches that they labeled with the antibodies differently. Both batches of tissues consisted of Hck-KO mice as a normalizing control.
| Dendritic spine analysis
Hemibrains diluted in TBST/sodium dodecyl sulfate (SDS) and 5% fat-free milk for 1 hr at room temperature. Membranes were washed in TBST thereafter and scanned using Odyssey Imaging System (LI-COR Biosciences).
| Protein extraction and western blot analysis
Band intensities were quantified with Image Studio software (version 5.2, LI-COR Biosciences) and normalized to that of tubulin which serves as protein loading control.
| Quantitative analysis of Aβ by ELISA
Aβ 40 and Aβ 42 were quantified in both detergent-soluble and -insoluble fractions, and in 7PA2-and CHO-CM by ELISA as described previously (Zumkehr et al., 2015) .
| RNA isolation and real-time polymerase chain reaction
Total RNA was isolated separately from the hippocampus and cortex of the mice using Direct-zol RNA MiniPrep (ZYMO Research). RNA purity and concentration were assessed using NanoDrop spectrophotometer, and 1 μg of total RNA was reversed-transcribed to cDNA using iScript cDNA Synthesis kit (Bio-Rad Laboratories). One microliter of the synthesized cDNA was then amplified via real-time polymerase chain reaction (PCR) using iTaq Universal SYBR Green Supermix (Bio-Rad Laboratories) on the CFX Connect Real-time system (Bio-Rad Laboratories). Sequences of the mouse primers used were as followed:
Parameters of the real-time PCR cycles were 95 C for 10 min for initial denaturing, 95 C for 30 s for denaturing, 60 C for 1 min for annealing, and 72 C for 1 min for extension. The last three parameters were repeated for 35 times before the melt curves were generated.
Quantification cycle (Cq) values and melt curves were determined by Bio-Rad Laboratories CFX Manager 3.1. Relative mRNA levels were calculated by the 2 −ΔΔCt method (Livak & Schmittgen, 2001 ) using Gapdh as the reference gene and genes expressed by WT mice as the calibrators.
| Novel object recognition
Novel object recognition (NOR) was conducted as previously described (Rodriguez-Ortiz et al., 2013) with some modifications. Mice were first habituated to the trainer by handling them for 2 min each in three consecutive days. The mice handling was then extended to another 5 min of habituation to a Plexiglas arena without objects.
After five consecutive days of habituation (day nine of the training), mice were habituated to the training room for 15 min before task training and 2 hr after (for memory retention). Mice were trained by exposing them to two identical objects placed side-by-side in the arena for 10 min. At 2 hr later, mice were allowed to explore one familiar object (i.e., object exposed before) and one novel (new) object in the arena for 5 min. Mice activities in the arena were recorded using video camera, which was later replayed to determine their exploration behaviors and quantified as recognition index. Recognition index (RI) indicates the relative time mouse spent in exploring the novel object, and significance from RI of 0.5 (chance level) using one-sample t test denotes NOR. Exploration was considered when mouse pointed its head toward an object at a distance of <2.5 cm with its neck extended and vibrissae moving. Simple proximity, chewing, and sitting on objects were not considered as exploratory behaviors.
Mice that did not explore both objects during training were not used for behavioral analysis. Objects used in this task were carefully selected to prevent preference or phobic behaviors. To eliminate olfactory cues, the objects and arena were thoroughly cleaned with 70% ethanol and the beddings were removed of droppings and stirred between mice.
| Object in place
Object in place (OIP) training was conducted on the day after NOR test, with similar procedures except for the set of objects used and the object placement. During task training, a new set of identical objects were placed side-by-side in the arena for mice to explore for 10 min. Two hours later, mice were exposed to the same set of identical objects, with one of the objects moved to either the left or right side of the arena. RI for OIP indicates the relative time mouse spent in exploring the object at the novel place.
| Morris water maze
Morris water maze (MWM) was conducted as described previously (Rodriguez-Ortiz et al., 2013) with some modifications. Mice were trained to locate a circular and transparent Plexiglas platform submerged at 1 cm beneath the surface of the water, which was invisible to them when they were swimming in the 1-m-diameter water tank.
The platform was placed in an equidistant position in a quadrant of the circular tank, and visual cues were placed on three sides of the wall for spatial reference. Mice were subjected to six training trials per day for three consecutive days whereby WT mice of 5-6 months old reached the training criterion of 25 s in escape latency by the third day of training. On the first 2 days of training, mice were placed on the platform for 30 s, and allowed to rest for 30 s in a dry cage. Trials involved placing the mice into the tank at one of the four designated starting points in a pseudorandom order. Mice were given up to 60 s to swim to the platform. If they failed to do so, they were manually guided to the platform. Once on the platform, they were left there for another 30 s, before being transferred to a dry cage to rest for 30 s.
On Day 3 of the training, mice were placed directly into the tank without prior placement on the platform. At 72 hr after the last training, the platform was removed and mice were tested by placing in the tank at the quadrant opposite of where the platform was supposed to be. At 60 s, mice were removed from the tank and allowed to rest for 30 s. Mice were next returned to the tank at the same location, but with the platform in the place this round. At 1 week after the last training, mice were again tested with platform removed from the tank.
All MWM trainings and tests were recorded by video camera and analyzed using VideoTrack system (ViewPoint Behavior Technology).
Behavioral performance was quantified in terms of escape latency (time taken to reach area occupied by platform during training), number of platform crosses (number of times mouse crosses the platform area during the 60 s), and % time spent in the target (with platform) and opposite (from platform) quadrants.
| Statistical analysis
All data are presented as mean AE SEM, and statistical analyses were done using GraphPad Prism 6. Values that were not within the prede- Given that the hippocampus is one of the earliest brain regions to be affected in AD (Braak, Braak, & Bohl, 1993) and in J20 mice Phagocytic efficiency (%) accounts for the weighted average of phagocytosed microspheres per cell. CHO-CM is the conditioned medium from CHO cells that was applied as a negative control as 7PA2 cells are derived from CHO cells. Both phagocytic efficiency (%) and % phagocytic cells analyses revealed that BV2 microglial phagocytic activity was stimulated by mOZ, LPS, and naturally secreted AβO in 7PA2-CM. However, in the presence of pan-Src (PP2) or Syk (BAY 61-3606) inhibitor, BV2 phagocytic activities were attenuated to that of the basal level, signifying that Hck/SFKs and Syk are responsible for these ligand-stimulated microglial phagocytosis. Data are expressed as mean AE SEM. n = 4-6 from three independent experiments. ***p < .001 and ****p < .0001 relative to no inhibitor (Fu, (Figure 4e-g ). Neither were differences observed in the total processes length per Iba1 + microglia (Supporting Information Figure S3a ) nor the number of Iba1 + microglia branches (Supporting Information Figure S3b ) around plaques between the genotypes. It appeared that the same number of microglia with similar morphologies was recruited to plaques, but covered the plaque area significantly lesser in J20/Hck-KO mice.
Having observed significant reduction in microglial phagocytosis after pharmacological inhibition of SFKs/Hck in BV2 cells, we examined whether genetic ablation of Hck in J20 mice recapitulated the same effect in vivo. Using confocal microscopy and Imaris volumetric and colocalization analysis, we quantified the volume of 6E10-positive plaques internalized in Iba1 + /CD68 + microglial phagolysosomes as previously described (Marsh et al., 2016) . Quantitative analysis of the Aβ internalization ratio revealed a significant 66% reduction in microglial phagocytic activity in J20/Hck-KO mice as compared to J20 mice (p = .0159, Figure 5 ).
Recent reports have shown that microglia play neuroprotective
role by containing Thioflavin-S plaques with extended processes, thereby making them more compact and less diffuse (Condello, Yuan, Schain, & Grutzendler, 2015; Yuan et al., 2016) . We examined these parameters using confocal microscopy and Imaris volumetric and automated analysis. While Hck deficiency did not modulate the Thioflavin-S plaque volume or the plaque intensity (Figure 6a and Supporting Information Figure S4a ,b), there was a trend toward increasing number of Thioflavin-S plaques, specifically at all volumes (p = .0866) or at 500-1000 μm 3 (p = .0714; Supporting Information Figure S4c ).
In addition, the sphericity of Thioflavin-S plaques showed a tendency to be reduced (p = .0788) in J20/Hck-KO mice (Figure 6b ), indicating that Hck deficiency partially resulted in more diffuse and less compact mature Aβ plaques. Analysis of Thioflavin-S plaque-associated microglia using Iba1-immunostaining showed that there was no change in the Thioflavin-S plaque volume covered by microglia per plaque volume per microglia between J20 and J20/Hck-KO mice (Figure 6c ).
Similarly, no difference was found in the number of microglia clustering around the plaques (Figure 6d ) or in the volume of microglia clustering on Thioflavin-S plaques per plaque volume per microglia (Figure 6e ). Further analysis of the microglial morphology showed no change in the total processes length of the microglia in each microglia (Figure 6f ) but revealed a trend toward decreasing branching of the microglia (p = .0756) in J20/Hck-KO mice (Figure 6g ). These data imply that the loss of Hck in J20 mice led to slightly more diffuse and less contained plaques surrounded by microglia with fewer branched processes.
As our in vivo data indicated some functional alterations of microglia around plaques, we next explored for changes in cellular signaling and inflammatory responses in J20/Hck-KO mice. Microglia were costained with CD11b, iNOS, and pSyk antibodies. To correlate with the (Figure 9a,b) .
Similarly, synaptophysin immunoreactivity in J20/Hck-KO mice Figure S6 .) Conversely, we did not find significant difference in the PSD95 or synaptophysin immunoreactivity between WT, Hck-KO, and J20 mice.
Next, we proceed to examine the dendritic spine morphology on the pyramidal neurons in the CA1 region, which is important for learning and memory (Kerchner & Nicoll, 2008) , and commonly found atrophy in AD patients (Kerchner et al., 2012) . Dendritic spines were classified according to their types, namely, filopodia, stubby and thin as immature spine or mushroom and branched as mature spine in the hippocampus (Penazzi et al., 2016; van der Zee, 2015) . Quantification of spine types relative to the length of the dendrites revealed a significant reduction of mushroom spine in J20/Hck-KO mice when compared with either WT (31%, p = .0440) or Hck-KO (37%, p = .0110, Figure 9c ,d). However, no significant difference in the number of any types of spines analyzed was detected between J20 and J20/Hck-KO mice. When we analyzed immature (filopodia, stubby, and thin) and mature (mushroom and branched) spines relative to total number of spines, J20/Hck-KO mice showed significantly more immature spines and less mature spines than WT (immature: 32% increase, p = .0419; mature: 29% decrease, p = .0419) or Hck-KO (immature: 47% increase, p = .0106; mature: 35% decrease, p = .0106) mice (Figure 9e ). We also found an increased trend of immature spines and reduced trend of mature spines in J20/Hck-KO mice relative to J20 mice (Figure 9e ). Taken together, the loss of mature spines in J20/Hck-KO was clearly evident when compared to WT or Hck-KO mice, but it was fairly marginal when compared to J20 mice. 
| DISCUSSION
Emerging evidence have shown that microglia exhibit impaired phagocytic activity that contribute to Aβ deposition and subsequent AD pathology (Malm et al., 2015; Mosher & Wyss-Coray, 2014) . Thus, understanding the molecular mechanisms that derail proper microglial phagocytic activity in AD is crucial in delineating the pathogenesis of AD. Hck is a phagocyte-specific tyrosine kinase among the SFKs (Guiet et al., 2008; Lowell et al., 1994) and possesses significant regulatory strength and altered expression in the microglia of sporadic AD patients (Zhang et al., 2013) . Hck signaling pathways have been implicated in diseases involving phagocytes, such as inflammatory diseases, human immunodeficiency virus-1 (HIV-1) infections, and leukemia (Guiet et al., 2008) . However, there is no report on the molecular assessment of Hck signaling in AD pathogenesis to date. On the contrary, Syk has been shown to be activated by tyrosine phosphorylation by the SFKs upon stimulated with Aβ (Combs, Johnson, Cannady, Quantitative analysis of Aβ internalization ratio revealed a 66% reduction in microglial phagocytic activity in J20/Hck-KO mice. Aβ internalization ratio was calculated by volume of Aβ within microglial phagolysosomes normalized to microglia number on the plaque and Aβ plaque volume in the field. Plaques were analyzed in the hemibrains of eight J20 (n = 18) and six J20/Hck-KO (n = 30) mice. Data are expressed as mean AE SEM from one section per mouse. *p < .05 relative to J20 mice Lehman, & Landreth, 1999; McDonald, Brunden, & Landreth, 1997; Sondag, Dhawan, & Combs, 2009 ) and mediated fibrillar Aβ-stimulated microglial phagocytosis (Koenigsknecht & Landreth, 2004) .
Nonetheless, the involvement of Syk in mediating AβO-stimulated microglial phagocytosis has not been shown.
Our in vitro BV2 cells phagocytosis assay showed that AβO at physiological levels as found in human AD brains (Calabrese et al., 2007) Corroborating with our in vitro study, we report novel findings that deleting Hck in J20 mice significantly augmented Aβ plaque deposition in the hippocampus and cortex, with no observable change in the full-length APP. On the other hand, we detected a significant reduction in C99 fragment in J20/Hck-KO mice that correlated with the drastic decrease in mature BACE1 level. BACE1 is an initial and rate-limiting enzyme for Aβ formation (Cole & Vassar, 2007) by first producing C99 fragment. It is interesting to observe attenuation of both C99 fragment and mature BACE1 levels when Hck was genetically ablated from either WT or J20 mice. While we cannot fully reported in previous studies (Skovronsky, Moore, Milla, Doms, & Lee, 2000; Vassar et al., 1999) .
Our in vivo results also suggest that Hck deficiency promotes microglia toward more proinflammatory state, which has been observed in longitudinal studies of microglial activation phenotypes in APP/PS1 AD mouse model (Jimenez et al., 2008) and in human AD patients (Fan, Brooks, Okello, & Edison, 2017) . In the mouse model study, Jimenez et al. (2008) observed an apparent reduction of Ym1 mRNA coupled with significant induction of iNos and Tnfα mRNA levels when comparing the hippocampi of 6-and 18-months-old APP/PS1 mice. Interestingly, the authors did not detect any modulation in the mRNA level of Arg1 as in our study. Likewise in the human protective role by forming a barrier around toxic protofibrillar plaques to prevent neuritic dystrophy, which is supported by a recent study (Zhao, Hu, Tsai, Li, & Gan, 2017 ). Condello's study was followed up by Yuan et al. (2016) who reported that removing microglial immunoreceptor-triggering receptor expressed on myeloid cells 2 (TREM2), or its adaptor protein-DNAX-binding protein of 12 kDa (DAP12), which acts upstream of SFKs and Syk , reduced microglia envelopment and plaque compaction in AD mice that contributed to severe axonal dystrophy. Similar observations of reduced microglia coverage around Aβ plaques owing to TREM2 deficiency were also made by other groups (Jay et al., 2017; Wang et al., 2016) . Consistent with these findings, we observed trend of less spherical, that is, more diffuse Thioflavin-S plaques clustered by fewer branched microglia when removing Hck in J20 mice. This implicates that Hck deficiency in J20 mice partially reduced microglial containment capability that resulted in more diffuse or less compact mature Aβ plaques. Likewise for 6E10-immunoreactive Aβ plaques, we detected a significant reduction in the plaque coverage by Hckdeficient microglia with concomitant increase in the plaque deposition. There is, however, some distinctions here, in that morphologically similar and same number of microglia were recruited to the less mature 6E10-positive plaques, but Hck removal seemingly resulted in smaller microglial clusters covering the plaques than that observed in Hck-sufficient J20 mice. This could, in part, affect the phagocytic efficiency of the Hck-deficient microglia, as they were less accessible to the plaques.
We noted that there was no change in the dendritic spine mor- however, did not lead to cognitive deficits as observed in our behavioral tests. Neither were any cognitive impairments observed in our , and J20/Hck-KO mice taken relative to that of Hck-KO mice revealed significant reduction in J20/Hck-KO mice at the DG (compared to J20 mice) and CA3 (compared to WT and J20 mice) regions. Data are expressed as mean AE SEM from one section per mouse with n = 6-8. *p < .05 and **p < .01 between indicated genotypes. (c) Representative images of dendritic spines in 6-to 8-months-old WT, Hck-KO, J20, and J20/Hck-KO mice were shown. Filopodia (yellow arrow), thin (green arrow), stubby (blue arrow), mushroom (red arrow), and branched (purple arrow) spines were indicated in the images. Scale bar, 5 μm. (d) Quantitative analyses of % filopodia, stubby, thin, mushroom, and branched spines in the SR region of hippocampal CA1 per 100 μm dendrite analyzed revealed significant reduction of mushroom spine in J20/Hck-KO mice relative to WT or Hck-KO mice. (e) A replot of the data by expressing % immature (sum of filopodia, stubby, and thin spines relative to total spine) and % mature (sum of mushroom and branched spines relative to total spine) spines showed more immature spine but fewer mature spine in J20/Hck-KO mice as compared to WT or Hck-KO mice. Data are expressed as mean AE SEM from four mice per genotype where 25-35 pyramidal neurons were analyzed for each mouse. *p < .05 relative to WT or Hck-KO mice 5-to 6-months-old J20 mice. It is apparent that the consequence of Hck elimination in the pathologically young J20 mice elicited an early neuropathological development, with increased plaque disposition and microglial dysfunction and inflammation, but the effects were not sufficient to impair cognitive function. This is plausible since deficiency of TREM2-another microglial activation modulator-revealed exacerbated AD-like pathology only at the later stage of the disease (Jay et al., 2017) .
There are evidence that high levels of pSyk were expressed in hyperactive microglia of AD mouse models and human AD brains (Satoh et al., 2012; Schweig et al., 2017) , which contributed to the secretion of pro-inflammatory cytokines upon stimulated by Aβ species (Combs, Karlo, Kao, & Landreth, 2001; Sondag et al., 2009 ). While we did not observe such microglial phenotypes in our pathologically young J20 mice yet, we detected elevated levels of pSyk and iNOS with Hck ablation. This signifies that Hck plays a more pivotal role than other SFKs in regulating microglial activities and neuroinflammation. It is noteworthy that high levels of iNOS in activated microglia have been reported to produce nitric oxide (NO) that impaired phagocytic activities (Kopec & Carroll, 2000) . In accordance to this, we observed augmented iNOS expression and dramatic attenuation in Aβ internalization owing to impaired phagocytosis in our Hck-deficient FIGURE 10 Knocking out Hck did not modulate cognitive phenotypes in J20 mice. (a-f) WT, Hck-KO, J20, and J20/Hck-KO mice of 5-6 months were subjected to a battery of behavioral tests, namely, NOR (a), OIP (b), and MWM (c-f). There were no significant differences in the recognition index (RI) of NOR (a) and OIP (b) tests between the genotypes during the 1, 3, and 5 min of the experiments. MWM training revealed that J20/Hck-KO mice took significantly longer escape latency than Hck-KO mice on the second day of training, but had comparable latency with WT and Hck-KO mice on the third day (c). n = 13-18, *p < .05 and ****p < .0001 relative to Hck-KO mice; # p < .05 and ### p < .001 relative to WT mice (repeated measures two-way ANOVA with multiple comparisons of performance by genotype per day). At 72 hr and 1 week after last MWM training, J20/Hck-KO showed trend of shorter but not significant escape latency than J20 mice in both MWM tests (d). The data coincided with slightly more crosses observed in J20/Hck-KO mice than J20 mice during the 72 hr and 1 week tests (e). There was no significant difference in the % time spent in the target (f) quadrant between the genotypes either. Data are expressed as mean AE SEM at n = 13-18 microglial cells. 
